Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of$ 0.23. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -26.09%. A quarter ago, it was expected that this medical device company focused on psychiatric disorders would post a loss of$ 0.27 per share when it actually produced a loss of $0.33, delivering a surprise of -22.22%.Over th ...